Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Highmark Interactive (HMRK) has commenced trading on the TSX Venture Exchange under the symbol HMRK
  • The listing follows the closing of the company’s qualifying transaction, consisting of the acquisition of Highmark Innovations Inc.
  • Highmark Interactive provides a complete solution for brain health through its digital brain health assessment tools and its network of virtual, in-clinic and hybrid clinics
  • Highmark Interactive (HMRK) is up 10 per cent on the day, trading at C$0.55 per share at 3 pm ET

Highmark Interactive (HMRK) has commenced trading on the TSX Venture Exchange.

The listing follows the closing of the company’s qualifying transaction, consisting of the acquisition of Highmark Innovations Inc. as well as the concurrent closing of the acquisitions of Complex Injury Rehab Inc. and Highmark Health Mississauga.

Dr. Sanjeev Sharma, CEO and Co-Founder of Highmark sat down with Caroline Egan to discuss the listing.

“The closing of our qualifying transaction and listing on the TSXV marks a major milestone for our company. We look forward to providing next generation technology leadership through our proprietary platforms. Our AI based engine will generate digital biomarkers which will enable new models of care to be deployed, including predictive analytics for enhanced remote physiologic and therapeutic monitoring. As we continue to execute on our strategy, we look forward to driving shareholder value through ongoing industry disruption.”

Highmark Interactive provides a complete solution for brain health through its proprietary digital brain health assessment tools and its growing network of virtual, in-clinic and hybrid clinics.

Highmark Interactive (HMRK) is up 10 per cent on the day, trading at C$0.55 per share at 3 pm ET.

More From The Market Herald
The Market Herald Video

" Avrupa Minerals (TSXV:AVU) reports new drill results at the Sesmarias Prospect

Avrupa Minerals (AVU) reports that drilling continues at the Sesmarias Copper-Zinc Prospect within the Alvalade Project in Portugal.
codikoat, covid protection

" PharmaDrug (CSE:PHRX) begins manufacturing PD-001 for treatment of rare cancers and COVID-19

PharmaDrug (PHRX) has begun manufacturing PD-001, its oral formulation of cepharanthine, for cancer and infectious disease studies.
Xigem Technologies - Director, Ezio D'Onofrio

" Xigem Technologies (CSE:XIGM) welcomes technology veteran to its board of directors

Xigem Technologies (XIGM) has appointed Mr. Ezio D’Onofrio, a technology industry veteran, to the company’s board of directors.

" Moovly Media (TSXV:MVY) signs reseller agreement with VMC Global, LLC

Moovly Media (MVY) has signed a reseller agreement with VMC Global, LLC.